CSIMarket
 
Decoy Therapeutics Inc   (DCOY)
 

DCOY's Market share relative to its competitors, as of Q1 2026

As of Q1 2026 (Revenue in Millions of $)

Date modified: 2026-08-29T06:32:56+00:00





COMPANY NAME REVENUES
12 Months Ending
Q1 2026
MARKET SHARE
12 Months
Q1 2026
MARKET SHARE
MRQ
Q1 2026
MARKET SHARE
A Quarter Before
Q4 2025
Decoy Therapeutics Inc 0.00 0.00% 0.00 % 0.00 %
Astrazeneca Plc 54,073.00 38.49% 73.44% 71.06%
Bristol myers Squibb Company 48,482.00 34.51% 14.37% 16.43%
Regeneron Pharmaceuticals Inc 14,919.60 10.62% 4.51% 5.10%
Vertex Pharmaceuticals Inc 12,218.00 8.70% 4.17% 3.93%
United Therapeutics Corporation 3,169.80 2.26% 0.98% 1.04%
124 more competitors available

Sign in to see all competitors for Decoy Therapeutics Inc .




DCOY's Market share relative to its competitors, as of Q1 2026 within the Industry
As of Q1 2026



COMPANY NAME MARKET SHARE
12 Months Ending
Q1 2026
MARKET SHARE
12 Months Ending
Q4 2025
MARKET SHARE
MRQ
Q1 2026
MARKET SHARE

Q4 2025
Decoy Therapeutics Inc 0.00% 0.00% 0.00 % 0.00 %
Astrazeneca Plc 38.63% 35.16% 73.53% 71.16%
Bristol myers Squibb Company 34.63% 36.99% 14.38% 16.45%
Regeneron Pharmaceuticals Inc 10.66% 11.01% 4.51% 5.11%
Vertex Pharmaceuticals Inc 8.73% 9.21% 4.17% 3.93%
United Therapeutics Corporation 2.26% 2.44% 0.98% 1.04%
121 more companies available

Sign in to see all industry competitors for Decoy Therapeutics Inc .




DCOY's Market share relative to its competitors, as of Q1 2026 within the Sector
As of Q1 2026



COMPANY NAME MARKET SHARE
12 Months Ending
Q1 2026
MARKET SHARE
12 Months Ending
Q4 2025
MARKET SHARE
MRQ
Q1 2026
MARKET SHARE

Q4 2025
Decoy Therapeutics Inc 0.00% 0.00% 0.00 % 0.00 %
Astrazeneca Plc 38.49% 35.03% 73.44% 71.06%
Bristol myers Squibb Company 34.51% 36.86% 14.37% 16.43%
Regeneron Pharmaceuticals Inc 10.62% 10.97% 4.51% 5.10%
Vertex Pharmaceuticals Inc 8.70% 9.18% 4.17% 3.93%
United Therapeutics Corporation 2.26% 2.43% 0.98% 1.04%
124 more companies available

Sign in to see all sector competitors for Decoy Therapeutics Inc .




Note: Market share is calculated based on total revenue. To get a more accurate picture of Decoy Therapeutics Inc's market divisions, geographic dispersion, segments, products, and services, visit Decoy Therapeutics Inc's Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.